机构

• 昆明植物研究所 [19]
• 合肥物质科学研究院 [6]
• 动物研究所 [4]
• 西北高原生物研究所 [2]
• 大连化学物理研究所 [2]
• 中国科学院大学 [2]
• 更多

采集方式

• OAI收割 [39]
• iSwitch采集 [2]

内容类型

• 期刊论文 [41]

发表日期

• 2025 [1]
• 2023 [2]
• 2022 [3]
• 2021 [4]
• 2020 [4]
• 2018 [3]
• 更多

学科主题

• Multidisci... [2]
• Plant Scie... [2]
• Biochemist... [1]
• Biophysics [1]

筛选

浏览/检索结果: 共41条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Wetland-to-Meadow Transition Alters Soil Microbial Networks and Stability in the Sanjiangyuan Region 期刊论文  OAI收割 MICROORGANISMS, 2025, 卷号: 13, 期号: 6 作者:  Wu, Guiling;  Gao, Jay;  Wang, Zhaoqi;  Du, Yangong   |  收藏  |   Multiple-Branch Optical Frequency Transfer Without the Frequency Allocation Constraints 期刊论文  OAI收割 JOURNAL OF LIGHTWAVE TECHNOLOGY, 2023, 卷号: 41, 期号: 17, 页码: 5529-5537 作者:  Shen, Jianguo;  Qiu, Ziang;  Xue, Ruimin;  Hu, Liang;  Liu, Jiao   |  收藏  |   Substantial uncertainties in global soil organic carbon simulated by multiple terrestrial carbon cycle models 期刊论文  OAI收割 LAND DEGRADATION & DEVELOPMENT, 2023, 卷号: 34, 期号: 11, 页码: 3225 作者:  Wang, Zhaoqi;  Lin, Yuanhao;  Cai, Lang;  Wu, Guiling;  Zheng, Kai   |  收藏  |   Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial 期刊论文  OAI收割 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 18 作者:  Li, Ning;  Zhu, Jianqing;  Yin, Rutie;  Wang, Jing;  Pan, Lingya   |  收藏  |   All-Passive Cascaded Optical Frequency Transfer 期刊论文  OAI收割 IEEE PHOTONICS TECHNOLOGY LETTERS, 2022, 卷号: 34, 期号: 8, 页码: 413-416 作者:  Zhang, Xiang;  Hu, Liang;  Deng, Xue;  Zang, Qi;  Liu, Jie   |  收藏  |   Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study 期刊论文  OAI收割 CLINICAL CANCER RESEARCH, 2022, 卷号: 28 作者:  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Jing;  Lin, Zhongqiu;  Yin, Rutie   |  收藏  |   Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial 期刊论文  OAI收割 GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162 作者:  Yang, Jiaxin;  Wu, Xiaohua;  Zhu, Jianqing;  Song, Liang;  Feng, Yanling   |  收藏  |   Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer and a time-to-progression after penultimate platinum-based chemotherapy of 6-12 or > 12 months: a subgroup analysis of the phase III NORA trial 期刊论文  OAI收割 GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162 作者:  Huang, Qidan;  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Danqing;  Yang, Jiaxin   |  收藏  |   Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Wang, Jing;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin   |  收藏  |   Efficacy of niraparib maintenance therapy in Chinese women with platinum-sensitive recurrent ovarian cancer with and without secondary cytoreductive surgery: Results from the NORA trial. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Wu, Lingying;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin   |  收藏  |